As of November 2024, Jiangsu Hengrui Medicine has a market cap of $40.65B. This makes Jiangsu Hengrui Medicine the world's 451th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $37.72B | -7.43% |
2023 | $40.75B | 17.39% |
2022 | $34.71B | -24.02% |
2021 | $45.68B | -45.40% |
2020 | $83.68B | 52.82% |
2019 | $54.75B | 99.10% |
2018 | $27.50B | -0.59% |
2017 | $27.66B | 81.93% |
2016 | $15.21B | 11.16% |
2015 | $13.68B | 70.37% |
2014 | $8.03B | 8.55% |
2013 | $7.40B | 38.80% |
2012 | $5.33B | 12.47% |
2011 | $4.74B | -25.86% |
2010 | $6.39B | 36.14% |
2009 | $4.69B | 63.59% |
2008 | $2.87B | -18.45% |
2007 | $3.52B | 128.37% |
2006 | $1.54B | 255.41% |
2005 | $433.58M | 18.28% |
2004 | $366.56M | 48.63% |
2003 | $246.62M | -16.44% |
2002 | $295.13M | -28.92% |
2001 | $415.21M | -26.92% |
2000 | $568.12M | - |